Shares of Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $11.52 and last traded at $11.40, with a volume of 395431 shares trading hands. The stock had previously closed at $9.94.
Cybin Trading Up 14.7 %
The company’s 50-day moving average is $6.79 and its 200 day moving average is $2.57. The firm has a market cap of $1.69 billion and a PE ratio of -41.42.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Recommended Stories
- Five stocks we like better than Cybin
- What is the Nikkei 225 index?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Breakout Alert: Qualcomm Just Hit The Rally Button
- How to Use the MarketBeat Excel Dividend Calculator
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
